72.11.Z - Scientific research and development activities
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
32.50.Z - Production of medical devices, instruments, and products, including dental products
46.46.Z - Wholesale trade of pharmaceutical and medical products
47.73.Z - Retail sale of pharmaceutical products
47.74.Z - Retail sale of medical and orthopedic products
62.01.Z - Activities related to programming, IT consulting, and related activities
62.09.Z - Activities related to programming, IT consulting, and related activities
72.19.Z - Scientific research and development activities
86.22.Z - Specialist medical practice
2019 | 2020 | 2021 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Assets | 18,8 | 23,2 | 29,5 | 27,2 |
Gross profit (loss) | 0,5 | 1,9 | 4,1 | 119,5 |
Net profit (loss) | 0,7 | 1,9 | 3,8 | 99,1 |
Cash | 0,1 | 0,8 | 0,1 | -83,1 |
Liabilities and provisions for liabilities | 2,5 | 2,7 | 5,1 | 92,7 |
Net income from sale | 3,2 | 6 | 12,7 | 110,9 |
Short time liabilities | 2,4 | 2,2 | 2,3 | 3 |
Equity capital | 16,2 | 20,6 | 24,4 | 18,7 |
Working assets | 10,3 | 10,8 | 18,7 | 73,1 |
Operating profit (EBIT) | 0,5 | 2,1 | 4,6 | 119,5 |
% | % | % | p.p. | |
Equity capital to total assets | 86,5 | 88,5 | 82,6 | -5,9 |
Gross profit margin | 14,6 | 31,1 | 32,4 | 1,3 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 273 | 135 | 66 | -69 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane